|
Glycitein,>99%
|
|
|
|
G 6983, Free Base,>99%
|
|
|
|
GDC-0941, Dimethanesulfonate Salt,>99%
|
|
|
|
Flavo
|
|
|
|
Gefitinib, Free Base,>99%
|
|
|
|
L86-8275
|
2-(2-氯苯基)-5,7-二羥基-8-[(3S,4R)-3-羥基-1-甲基-4-哌啶基]苯并吡喃-4-酮
|
146426-40-6
|
|
Fenretinide,>99%
|
|
|
|
Fingolimod, Hydrochloride Salt,>99%
|
|
|
|
GDC-0941, Free Base,>99%
|
|
|
|
GSK2118436B
|
達帕菲尼甲磺酸鹽
|
1195768-06-9
|
|
GW1516
|
GW501516
|
317318-70-0
|
|
Halochondrine A
|
岡田酸銨鹽(高純度)
|
155716-06-6
|
|
HA-1077, Monohydrochloride Salt
|
|
|
|
Gemcitabine, Free Base,>99%
|
|
|
|
GSK-1120212
|
曲美替尼
|
871700-17-3
|
|
GW 572016X
|
|
|
|
GSK-2118436
|
5-[2-[4-[2-(二甲基氨基)乙氧基]苯基]-5-(4-吡啶基)-1H-咪唑-4-基]-2,3-二氫-1-茚酮肟
|
405554-55-4
|
|
Gilenia
|
2-氨基-2-[2-(4-辛基苯基)乙基]-1,3-丙二醇
|
162359-55-9
|
|
Genistin 6"-O-Malonate
|
丙二酰染料木苷
|
51011-05-3
|
|
GW2580, Free Base,>99%
|
|
|
|
GSK2110183C
|
GSK-2110183C
|
1047644-62-1
|
|
Gilena
|
|
|
|
GSK2110183B
|
N-((S)-1-氨基-3-(3-氟苯基)丙-2-基)-5-氯-4-(4-氯-1-甲基-1H-吡唑-5-基)噻吩-2-甲酰胺鹽酸鹽
|
1047645-82-8
|
|
GSK-2118436A
|
達拉非尼
|
1195765-45-7
|
|
Geldanomycin
|
|
|
|
GW501516, Free Acid,>99%
|
|
|
|
Gemcitabine, Hydrochloride Salt,>99%
|
|
|
|
Gilotrif
|
|
|
|
Genistin 6"-O-Acetate
|
6"-O-乙酰染料木苷
|
73566-30-0
|
|
Imatinib, Free Base,>99%
|
|
|
|
INCB18424
|
S-魯索替尼
|
941685-37-6
|
|
Xabine
|
|
|
|
GSK-1363089
|
N-[3-氟-4-[[6-甲氧基-7-[[3-(嗎啉-4-基)丙基]氧]喹啉-4-基]氧]苯基]-N'-(4-氟苯基)環(huán)丙烷-1,1-二甲酰胺
|
849217-64-7
|
|
Wortmannin,>99%
|
|
|
|
XL-184
|
卡博替尼
|
849217-68-1
|
|
Zolinza
|
|
|
|
YM155
|
4,9-二氫-1-(2-甲氧基乙基)-2-甲基-4,9-二氧代-3-(2-吡嗪甲基)-1H-萘并[2,3-D]咪唑溴化物
|
781661-94-7
|
|
Zydelig
|
|
|
|
ZSTK474, Free Base,>99%
|
|
|
|
Y-27632, Free Base,>99%
|
Y-27632二鹽酸鹽
|
146986-50-7
|
|
Zotarolimus, Free Base,>98%
|
|
|
|
LDK-378
|
色瑞替尼
|
1032900-25-6
|
|
ZoMaxx
|
|
|
|
Z-VAD-FMK, Methyl Ester,>99%
|
|
|
|
Z-VAD-FMK, Free Acid,>99%
|
|
|
|
Y27
|
|
|
|
Z-Val-Ala-Asp-FMK, Methyl Ester
|
|
|
|
Y-27632, Dihydrochloride Salt,>99%
|
Y27632 (HYDROCHLORIDE)
|
129830-38-2
|
|
Fasudil, Dihydrochloride Salt
|
|
|
|
Farmiblastina
|
|
|
|
Everolimus,>99%
|
|
|
|
Explanation of the Bosutinib Problem and Bosutinib Isomer 1,99%
|
|
|
|
Faridak
|
|
|
|
Giotrif
|
|
|
|
Glamox
|
|
|
|
Glycitin 6"-O-Acetate
|
6''-O-乙酰黃豆黃苷
|
134859-96-4
|
|
G 6976,>99%
|
|
|
|
Go 6983
|
[3-[1-[3-(二甲基氨基)丙基]-5-甲氧基-1H-吲哚-3-基]-4-(1H-吲哚-3-基)-1H-吡咯-2,5-二酮]
|
|
|
Glycitin 6"-O-Malonate
|
6''-O-MALONYLGLYCITIN
|
137705-39-6
|
|
Goe 6983
|
3-[1-[3-(二甲基氨基)丙基]-5-甲氧基-1H-吲哚-3-基]-4-(1H-吲哚-3-基)-1H-吡咯-2,5-二酮
|
133053-19-7
|
|
G 5549
|
|
|
|
Idelalisib, Free Base,>99%
|
|
|
|
INCB018424
|
魯索利替尼磷酸鹽
|
1092939-17-7
|
|
Imbruvica
|
|
|
|
Ibrutinib, Free Base,>99%
|
|
|
|
Imatinib Mesylate
|
伊馬替尼
|
152459-95-5
|
|
Imatinib, Methanesulfonate Salt,>99%
|
|
|
|
Iclusig
|
|
|
|
HKI-272
|
|
|
|
HhAntag691
|
|
|
|
Isoliquiritigenin,>99%
|
|
|
|
Ingenol 3-Hexanoate,99%
|
|
|
|
Irinotecan, Hydrochloride Salt, Trihydrate,>99%
|
|
|
|
IPI-145
|
IPI-145
|
1201438-56-3
|
|
Ingenol 3-Angelate,>99%
|
|
|
|
INK-1197
|
|
|
|
Ionomycin, Free Acid,>99%
|
|
|
|
Intedanib Esylate
|
|
|
|
Ingenol 3-Angelate 20-Acetate,99%
|
|
|
|
Ionomycin, Calcium Salt,>99%
|
|
|
|
INK128, Free Base,>99%
|
|
|
|
Ingenyl 3-Angelate 20-Acetate
|
|
|
|
Ingenyl 3-Angelate]
|
|
|
|
KRX-0401
|
哌立福辛
|
157716-52-4
|
|
K252a,>99%
|
|
|
|
Kinavet
|
|
|
|
K252c,>99%
|
|
|
|
JNJ-10198409, Free Base,>99%
|
|
|
|
K-252a
|
K-252A
|
99533-80-9
|
|
Jakafi
|
魯索替尼
|
941678-49-5
|
|
KY 12420
|
渥曼青霉素
|
19545-26-7
|
|
JTP-74057
|
曲美替尼二甲亞砜
|
1187431-43-1
|
|
VX-702, Free Base,>99%
|
|
|
|
LCP-Siro
|
|
|
|
Lapatinib, Di-p-Toluenesulfonate Salt,>99%
|
|
|
|
Lapatinib, Free Base,>99%
|
|
|
|
LC Labs XP/XR
|
|
|
|
LCR sulfate
|
|
|
|
Leelamine, Free Base,>99%
|
|
|
|
Leelamine, Hydrochloride Salt,>99%
|
|
|